Online Course Registration

If a webinar is recorded for viewing at a later date, it will be available on our page for online course registration. Please visit to register to view the recording.


Price: $0.00
Price: $175.00
This program has as focus on the pharmacist's role in the are of people with insomnia, anxiety, and depression.   This will include a review of the clinical features of depression and anxiety, their pharmacotherapies and tools are resources that pharmacists can recommend for self-help.  The management of insomnia, pharmacotherapy and their discontinuation.   Learning Objectives: Deepen their understanding of their patient’s personal experiences and health needs associated with living with insomnia, anxiety, and depression
Price: $0.00
This learning module is designed to provide information for pharmacists and technicians on the Nova Scotia Take Home Naloxone Program (THN), including how to become a register THN Program Site, and THN Program form requirements.  The goal of the module is, to enhance your knowledge and awareness of opioid use disorder, the safety and effectiveness of naloxone, harm reduction principles and the current opioid crisis in Canada.
Price: $879.00
PANS Managing Chronic Disease Certificate Program Outline (Accredited by Dalhousie Continuing Pharmacy Education) The following courses are included:
Price: $350.00
This program will cover the topics listed in the course outline. Each module includes written content along with a recorded voice reviewing the slide topics. This will support both visual and auditory learning styles. The modules include interactive activities to keep the learner engaged. These may be in the form of written responses, games, or multiple-choice questions. At the end of each Section, there is a Quiz to test their knowledge. In some cases, there will be specific policies or procedures at a pharmacy that will be unique to your location.
Price: $275.00
Pharmacogenomics is the study of how a person’s genes can affect their response to medications. Combining genetic information with clinical data is an intervention that may improve the safety and effectiveness of medication therapy.
Price: $15.00
Recorded on January 12, 2021
Price: $35.00
Session Learning Objectives:
Price: $30.00
A Subcutaneous Depot Buprenorphine for the treatment of Opioid Use Disorder is now available in Canada.   PANS is please to provide a webinar, for pharmacists and technicians to learn more about this new treatment option.   Upon completion of this program, participants will be able to: Discuss the pharmacology of buprenorphine/naloxone sublingual tablets for context Discuss the new depot buprenorphine injection and it’s mechanism of release Discuss current evidence on the use of subcutaneous depot buprenorphine for Opioid Use Disorder (OUD)